Last edition
News about "antibody-drug conjugates "
Lantern Pharma Launches Innovative AI-Powered Module to Advance ADC Development for Cancer
The global ADC market is projected to reach USD 30.4 billion by 2028, growing at a CAGR of 41.7 percent, with several recently approved ADCs achieving blockbuster status with annual sales exceeding USD 1 billion.
Antibody-drug Conjugates | 28/01/2025 | By Aishwarya
NJ Bio Partners with Charles River to Accelerate ADC Development
The biggest benefit of the Charles River and NJ Bio alliance is that clients can receive seamless complementary services to enhance outcomes and accelerate time-to-market for their ADCs.
Antibody Drug Conjugates | 08/11/2024 | By Aishwarya
AstraZeneca to Establish USD 1.5 Billion Manufacturing Facility for ADCs in Singapore
AstraZeneca has decided to build a USD 1.5 billion manufacturing facility in Singapore for antibody-drug conjugates (ADCs), enhancing the global supply of its ADC portfolio.
Antibody-drug Conjugates | 20/05/2024 | By Aishwarya | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy